ArticleCardiovascular drugs and therapy2026

Precision Secondary Prevention after Myocardial Infarction: Who Still Benefits from β-Blockade?

Qiaoqiao Zheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.